Risks of presymptomatic direct-to-consumer genetic testing
- PMID: 20843242
- PMCID: PMC8806904
- DOI: 10.1056/NEJMp1006029
Risks of presymptomatic direct-to-consumer genetic testing
Similar articles
-
Science and regulation. Regulating direct-to-consumer personal genome testing.Science. 2010 Oct 8;330(6001):181-2. doi: 10.1126/science.1194006. Science. 2010. PMID: 20929761 No abstract available.
-
In search of a coherent framework: options for FDA oversight of genetic tests.Food Drug Law J. 2007;62(4):617-52. Food Drug Law J. 2007. PMID: 18557224 No abstract available.
-
Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.Nature. 2010 Aug 12;466(7308):817-8. doi: 10.1038/466817a. Nature. 2010. PMID: 20703288 No abstract available.
-
Assessment of US pathway for approving medical devices for rare conditions.BMJ. 2014 Jan 17;348:g217. doi: 10.1136/bmj.g217. BMJ. 2014. PMID: 24443478 Review. No abstract available.
-
Translation of pharmacogenetics into clinically relevant testing modalities.Clin Pharmacol Ther. 2007 Oct;82(4):373-6. doi: 10.1038/sj.clpt.6100350. Clin Pharmacol Ther. 2007. PMID: 17851577 Review.
Cited by
-
Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk.J Community Genet. 2018 Jul;9(3):217-225. doi: 10.1007/s12687-017-0339-z. Epub 2017 Nov 13. J Community Genet. 2018. PMID: 29130150 Free PMC article.
-
Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing.PeerJ. 2013 Feb 12;1:e8. doi: 10.7717/peerj.8. Print 2013. PeerJ. 2013. PMID: 23638402 Free PMC article.
-
Precision public health-the Emperor's new clothes.Int J Epidemiol. 2019 Feb 1;48(1):1-6. doi: 10.1093/ije/dyy184. Int J Epidemiol. 2019. PMID: 30212875 Free PMC article. No abstract available.
-
Attitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics.J Pers Med. 2013 Oct 14;3(4):275-87. doi: 10.3390/jpm3040275. J Pers Med. 2013. PMID: 25562728 Free PMC article.
-
Time for physicians to be aware of molecular genetic testing. Report from the 3rd Viareggio Health Festival.Multidiscip Respir Med. 2011 Feb 28;6(1):47-9. doi: 10.1186/2049-6958-6-1-47. Multidiscip Respir Med. 2011. PMID: 22958714 Free PMC article. No abstract available.
References
-
- Food and Drug Administration. Medical devices. Letters to industry. (Accessed August 2, 2010, at http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/ucm111104.htm.)
-
- Holtzman NA. Promoting safe and effective genetic tests in the United States: work of the task force on genetic testing. Clin Chem 1999;45(5):732–8. (Also available at http://www.genome.gov/10001733.) - PubMed
-
- Food and Drug Administration. Medical devices. Roche AmpliChip Cytochrome P450 Genotyping test and Affymetrix GeneChip Microarray Instrumentation System — K042259. (Accessed August 2, 2010, at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApp....)
-
- Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Chron 1968;22:473–83.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical